|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang T, Hu Y, Yang N, Yu S and Pu X: The
microRNA-34 family and its functional role in lung cancer. Am J
Clin Oncol. 47:448–457. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morales-Martínez M and Vega MI: Role of
MicroRNA-7 (MiR-7) in cancer physiopathology. Int J Mol Sci.
23:90912022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saikia M, Paul S and Chakraborty S: Role
of microRNA in forming breast carcinoma. Life Sci. 259:1182562020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roufayel R and Kadry S. MicroRNAs: Crucial
regulators of stress. Microrna. 9:93–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwok ZH, Zhang B, Chew XH, Chan JJ, Teh V,
Yang H, Kappei D and Tay Y: Systematic analysis of intronic mirnas
reveals cooperativity within the multicomponent FTX locus to
promote colon cancer development. Cancer Res. 81:1308–1320. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun J, Deng L and Gong Y: MiR-145-5p
inhibits the invasion of prostate cancer and induces apoptosis by
inhibiting WIP1. J Oncol. 2021:44127052021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang WW, Wang BY, Chen SH, Chien PJ, Sheu
GT and Lin CH: miR-145-5p targets Sp1 in non-small cell lung cancer
cells and links to BMI1 induced pemetrexed resistance and
epithelial-mesenchymal transition. Int J Mol Sci. 23:153522022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai HX, Qiu XM, Xu CH and Guo JQ:
MiRNA-145-5p inhibits gastric cancer progression via
the serpin family E member 1-extracellular signal-regulated
kinase-1/2 axis. World J Gastrointest Oncol. 16:2123–2140. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bellissimo T, Tito C, Ganci F, Sacconi A,
Masciarelli S, Di Martino G, Porta N, Cirenza M, Sorci M, De
Angelis L, et al: Argonaute 2 drives miR-145-5p-dependent gene
expression program in breast cancer cells. Cell Death Dis.
10:172019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Z, Liu W, Huang T, Li J, Hu H, Xu X
and Fan Z: CircCPA4 induces ASCT2 expression to promote tumor
property of non-small cell lung cancer cells in a
miR-145-5p-dependent manner. Thorac Cancer. 15:764–777. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chu DX, Jin Y, Wang BR, Jiao Y, Zhang CK,
Guo ZH, Hu SZ and Li N: LncRNA HOTAIR enhances
epithelial-to-mesenchymal transition to promote the migration and
invasion of liver cancer by regulating NUAK1 via epigenetic
inhibition miR-145-5p expression. J Cancer. 14:2329–2343. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Agostino S, Canu V, Donzelli S, Pulito
C, Sacconi A, Ganci F, Valenti F, Goeman F, Scalera S, Rollo F, et
al: HSF-1/miR-145-5p transcriptional axis enhances hyperthermic
intraperitoneal chemotherapy efficacy on peritoneal ovarian
carcinosis. Cell Death Dis. 14:5352023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Wang X, Li Y, Han J, Gao X, Li S
and Wang F: c-Myb facilitates immune escape of esophageal
adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. Clin
Transl Med. 11:e4642021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Donzelli S, Mori F, Bellissimo T, Sacconi
A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F,
Pompili A, et al: Epigenetic silencing of miR-145-5p contributes to
brain metastasis. Oncotarget. 6:35183–35201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu S, Zhang Y, Zhou G and Liu A:
Bidirectional negative feedback actions of DNMT3A and miR-145 in
regulating autophagy in cardiac fibroblasts and affecting
myocardial fibrosis. J Bioenerg Biomembr. 55:341–352. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agrawal R, Pandey P, Jha P, Dwivedi V,
Sarkar C and Kulshreshtha R: Hypoxic signature of microRNAs in
glioblastoma: Insights from small RNA deep sequencing. BMC
Genomics. 15:6862014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu ZY, Peng J, Shi ZZ, Chen XL, Cheng HZ,
Wang H, Wang Y, Wang GP, Jiang W and Peng H: Silencing linc00662
inhibits cell proliferation and colony formation of lung cancer
cells via regulating the miR-145-5p-PAFAH1B2 axis. Biochem Cell
Biol. 99:330–338. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abtin M, Nafisi N, Hosseinzadeh A,
Kadkhoda S, Omranipour R, Sahebi L, Razipour M, Ghafouri-Fard S and
Shakoori A: Inhibition of breast cancer cell growth and migration
through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1
axis. Noncoding RNA Res. 9:367–375. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He J, Yan H, Wei S and Chen G: LncRNA
ST8SIA6-AS1 promotes cholangiocarcinoma progression by suppressing
the miR-145-5p/MAL2 axis. Onco Targets Ther. 14:3209–3223. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou T, Chen S and Mao X: miR-145-5p
affects the differentiation of gastric cancer by targeting KLF5
directly. J Cell Physiol. 234:7634–7644. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding Y, Cao F, Sun H, Wang Y, Liu S, Wu Y,
Cui Q, Mei W and Li F: Exosomes derived from human umbilical cord
mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit
pancreatic ductal adenocarcinoma progression. Cancer Lett.
442:351–361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He S, Yu G, Peng K and Liu S:
MicroRNA-145-5p suppresses fascin to inhibit the invasion and
migration of cervical carcinoma cells. Mol Med Rep. 22:5282–5292.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou J, Zhang X, Li W and Chen Y:
MicroRNA-145-5p regulates the proliferation of epithelial ovarian
cancer cells via targeting SMAD4. J Ovarian Res. 13:542020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Men Y, Zhang L and Ai H: MicroRNA-145-5p
over-expression suppresses proliferation, migration and invasion
and promotes apoptosis of human endometrial cancer cells by
targeting dual specific phosphatase 6. Nan Fang Yi Ke Da Xue Xue
Bao. 40:61–66. 2020.(In Chinese). PubMed/NCBI
|
|
26
|
Zhu J and Zhang F: Circular RNA VANGL1
knockdown suppressed viability, promoted apoptosis, and increased
doxorubicin sensitivity through targeting miR-145-5p to regulate
SOX4 in bladder cancer cells. Open Med (Wars). 16:1010–1021. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Le Hars M, Castro-Vega LJ, Rajabi F,
Tabatadze D, Romero M, Pinskaya M and Groisman I: Pro-tumorigenic
role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in
prostate cancer. Biol Direct. 18:382023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng Z, Chen Z, Zhong Q, Zhu D, Xie Y,
Shangguan W and Xie W: CircPVT1 promotes progression in clear cell
renal cell carcinoma by sponging miR-145-5p and regulating TBX15
expression. Cancer Sci. 112:1443–1456. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang T, Yang J, Gong F, Li L and Li A:
Long non-coding RNA CASC9 promotes the progression of
retinoblastoma via interacting with miR-145-5p. Cell Cycle.
19:2270–2280. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen F, Li XH, Liu C, Zhang Y and Wang RJ:
Circ-ABCB10 accelerates the malignant progression of oral squamous
cell carcinoma by absorbing miRNA-145-5p. Eur Rev Med Pharmacol
Sci. 24:681–690. 2020.PubMed/NCBI
|
|
31
|
Li H, Pan R, Lu Q, Ren C, Sun J, Wu H, Wen
J and Chen H: MicroRNA-145-5p inhibits osteosarcoma cell
proliferation by targeting E2F transcription factor 3. Int J Mol
Med. 45:1317–1326. 2020.PubMed/NCBI
|
|
32
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and
Shi ZZ: miR-145-5p suppresses tumor cell migration, invasion and
epithelial to mesenchymal transition by regulating the Sp1/NF-κB
signaling pathway in esophageal squamous cell carcinoma. Int J Mol
Sci. 18:18332017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong G, Zhang S, Shen S, Sun L, Wang X,
Wang H, Wu J, Liu T, Wang C, Wang H, et al: SPATS2, negatively
regulated by miR-145-5p, promotes hepatocellular carcinoma
progression through regulating cell cycle. Cell Death Dis.
11:8372020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei Q, Liu G, Huang Z, Huang Y, Huang L,
Huang Z, Wu X, Wei H and Pu J: LncRNA MEG3 inhibits tumor
progression by modulating macrophage phenotypic polarization via
miR-145-5p/DAB2 axis in hepatocellular carcinoma. J Hepatocell
Carcinoma. 10:1019–1035. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng X, Shen T, Liu P, Fang S, Yang Z, Li
Y and Dong J: mir-145-5p is a suppressor of colorectal cancer at
early stage, while promotes colorectal cancer metastasis at late
stage through regulating AKT signaling evoked EMT-mediated anoikis.
BMC Cancer. 22:11512022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu Z, Wu Q, Zhang M, Tong J, Zhong B and
Yuan K: Hsa_circ_0016760 exacerbates the malignant development of
non-small cell lung cancer by sponging miR-145-5p/FGF5. Oncol Rep.
45:501–512. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Song Y, Yu B and Yu Y: TNFAIP2
promotes non-small cell lung cancer cells and targeted by
miR-145-5p. DNA Cell Biol. 39:1256–1263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pei X, Chen SW, Long X, Zhu SQ, Qiu BQ,
Lin K, Lu F, Xu JJ, Zhang PF and Wu YB: circMET promotes NSCLC cell
proliferation, metastasis, and immune evasion by regulating the
miR-145-5p/CXCL3 axis. Aging (Albany NY). 12:13038–13058. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang W, Zhang X, Tan W, Gao J, Pan L, Ye
X, Chen L and Zheng W: miR-145-5p suppresses breast cancer
progression by inhibiting SOX2. J Surg Res. 236:278–287. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fan S, Chen P and Li S: miR-145-5p
inhibits the proliferation, migration, and invasion of esophageal
carcinoma cells by targeting ABRACL. Biomed Res Int.
2021:66925442021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shi W, Gao Z, Song J and Wang W: Silence
of FOXD2-AS1 inhibited the proliferation and invasion of esophagus
cells by regulating miR-145-5p/CDK6 axis. Histol Histopathol.
35:1013–1021. 2020.PubMed/NCBI
|
|
42
|
Wang S, Wang T and Gu P: microRNA-145-5p
inhibits migration, invasion, and metastasis in hepatocellular
carcinoma by inhibiting ARF6. Cancer Manag Res. 13:3473–3484. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Su Y, Yu T, Wang Y, Huang X and Wei X:
Circular RNA circDNM3OS functions as a miR-145-5p sponge to
accelerate cholangiocarcinoma growth and glutamine metabolism by
upregulating MORC2. Onco Targets Ther. 14:1117–1129. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu X, Ma X, Jia Y, Wu X and Yan Z:
Linc-ROR regulates POU5F1 and SOX2 b competitively binding
miR-145-5p to affect the proliferation and migration of gastric
cancer cells. Cell Transplant. 32:96368972311789022023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang X, Bai X, Yan Z, Guo X and Zhang Y:
The lncRNA TUG1 promotes cell growth and migration in colorectal
cancer via the TUG1-miR-145-5p-TRPC6 pathway. Biochem Cell Biol.
99:249–260. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen Q, Zhou L, Ye X, Tao M and Wu J:
miR-145-5p suppresses proliferation, metastasis and EMT of
colorectal cancer by targeting CDCA3. Pathol Res Pract.
216:1528722020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao H, Pan G, Tang S, Zhong N, Liu H, Zhou
H, Peng Q and Zou Y: miR-145-5p regulates the proliferation,
migration and invasion in cervical carcinoma by targeting KLF5.
Onco Targets Ther. 13:2369–2376. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pan Y, Huang Q, Peng X, Yu S and Liu N:
Circ_0015756 promotes ovarian cancer progression via the
miR-145-5p/PSAT1 axis. Reprod Biol. 22:1007022022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang H, Jiang M, Liu Q, Han Z, Zhao Y and
Ji S: miR-145-5p inhibits the proliferation and migration of
bladder cancer cells by targeting TAGLN2. Oncol Lett. 16:6355–6360.
2018.PubMed/NCBI
|
|
50
|
Tsai YM, Wu KL, Chang YY, Chang WA, Huang
YC, Jian SF, Tsai PH, Lin YS, Chong IW, Hung JY and Hsu YL: Loss of
miR-145-5p causes ceruloplasmin interference with PHD-Iron axis and
HIF-2α stabilization in lung adenocarcinoma-mediated angiogenesis.
Int J Mol Sci. 21:50812020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Guan X and Guan Y: miR-145-5p attenuates
paclitaxel resistance and suppresses the progression in
drug-resistant breast cancer cell lines. Neoplasma. 67:972–981.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhu Y, Ren J, Wu X, Zhang Y, Wang Y, Xu J,
Tan Q, Jiang Y and Li Y: lncRNA ENST00000422059 promotes cell
proliferation and inhibits cell apoptosis in breast cancer by
regulating the miR-145-5p/KLF5 axis. Acta Biochim Biophys Sin
(Shanghai). 55:1892–1901. 2023.PubMed/NCBI
|
|
53
|
Li Y, Yu J, Zhang Y, Peng C, Song Y and
Liu S: Advances in targeted therapy of cholangiocarcinoma. Ann Med.
56:23101962024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI
|
|
55
|
Teng F, Zhang JX, Chen Y, Shen XD, Su C,
Guo YJ, Wang PH, Shi CC, Lei M, Cao YO and Liu SQ: LncRNA
NKX2-1-AS1 promotes tumor progression and angiogenesis via
upregulation of SERPINE1 expression and activation of the VEGFR-2
signaling pathway in gastric cancer. Mol Oncol. 15:1234–1255. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Du Q, Zhang M, Gao A, He T and Guo M:
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by
activating Wnt signaling. Cancer Biol Ther. 25:23029242024.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dobre M, Herlea V, Vlăduţ C, Ciocîrlan M,
Balaban VD, Constantinescu G, Diculescu M and Milanesi E:
Dysregulation of miRNAs targeting the IGF-1R pathway in pancreatic
ductal adenocarcinoma. Cells. 10:18562021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wu L, Zhou WQ, Yuan LN, Li J and Pei ML:
Role of miR-145-5p targeting ARK5 in regulating the proliferation
and apoptosis of human epithelial ovarian cancer cells. Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 43:669–676. 2021.(In Chinese). PubMed/NCBI
|
|
60
|
Rohini M, Arumugam B, Vairamani M and
Selvamurugan N: Stimulation of ATF3 interaction with Smad4 via
TGF-β1 for matrix metalloproteinase 13 gene activation in human
breast cancer cells. Int J Biol Macromol. 134:954–961. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sun G, Tian J, Xiao Y and Zeng Y: Circular
RNA circ_0005667 promotes cisplatin resistance of endometrial
carcinoma cells by regulating IGF2BP1 through miR-145-5p.
Anticancer Drugs. 34:816–826. 2023.PubMed/NCBI
|
|
63
|
Du C, Waltzer WC, Wilusz JE, Spaliviero M,
Darras F and Romanov V: Circular STAG2 RNA modulates bladder cancer
progression via miR-145-5p/TAGLN2 and is considered as a biomarker
for recurrence. Cancers (Basel). 16:9782024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu C, Chen J, Cong Y, Chen K, Li H, He Q,
Chen L, Song Y and Xing Y: PROX1 drives neuroendocrine plasticity
and liver metastases in prostate cancer. Cancer Lett.
597:2170682024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ji S, Shi Y, Yang L, Zhang F, Li Y and Xu
F: miR-145-5p inhibits neuroendocrine differentiation and tumor
growth by regulating the SOX11/MYCN axis in prostate cancer. Front
Genet. 13:7906212022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang L, Yu R, Li C, Dang Y, Yi X and Wang
L: Circ_0026416 downregulation blocks the development of colorectal
cancer through depleting MYO6 expression by enriching miR-545-3p.
World J Surg Oncol. 19:2992021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Armstrong L, Willoughby CE and McKenna DJ:
The suppression of the epithelial to mesenchymal transition in
prostate cancer through the targeting of MYO6 using MiR-145-5p. Int
J Mol Sci. 25:43012024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Tannir NM, Formiga MN, Penkov K, Kislov N,
Vasiliev A, Skare N, Hong W, Dai S, Tang L, Qureshi A, et al:
Bempegaldesleukin plus nivolumab versus sunitinib or cabozantinib
in previously untreated advanced clear cell renal cell carcinoma: A
phase III randomized study (PIVOT-09). J Clin Oncol. 42:2800–2811.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lv Q, Ma C, Li H, Tan X, Wang G, Zhang Y
and Wang P: Circular RNA microarray expression profile and
potential function of circ0005875 in clear cell renal cell
carcinoma. J Cancer. 11:7146–7156. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sun J, Cheng W, Guo S, Cai R, Liu G, Wu A
and Yin J: A ratiometric SERS strategy for the prediction of cancer
cell proportion and guidance of glioma surgical resection. Biosens
Bioelectron. 261:1164752024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang Q, Cheng Z, Shi L and Mao G:
miR-145-5p inhibits the proliferation of glioma stem cells by
targeting translationally controlled tumor protein. J Cancer.
13:1490–1500. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yang Y, Ji N, Teng QX, Cai CY, Wang JQ, Wu
ZX, Lei ZN, Lusvarghi S, Ambudkar SV and Chen ZS: Sitravatinib, a
tyrosine kinase inhibitor, inhibits the transport function of ABCG2
and restores sensitivity to chemotherapy-resistant cancer cells in
vitro. Front Oncol. 10:7002020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hua L, Huang L, Zhang X, Feng H and Shen
B: Knockdown of circular RNA CEP128 suppresses proliferation and
improves cytotoxic efficacy of temozolomide in glioma cells by
regulating miR-145-5p. Neuroreport. 30:1231–1238. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gregersen PA, Jensen PS, Christensen R,
Lohmann D, Racher H, Gallie B and Urbak SF: Retinoblastoma caused
by an RB1 variant with unusually low penetrance in a Danish family.
Eur J Med Genet. 70:1049562024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Panchannavar GS and Angadi PV: Tumor
budding is a prognostic marker for overall survival and not for
lymph node metastasis in oral squamous cell carcinoma-systematic
review update and meta-analysis. J Oral Biol Craniofac Res.
14:362–369. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yu J, Lou Y, Hou M, Ma X and Wang L:
Circ_0058063 contributes to oral squamous cell carcinoma
development by sponging miR-145-5p and upregulating SERPINE1. J
Oral Pathol Med. 51:630–637. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Coca-Pelaz A, Shah JP, Hernandez-Prera JC,
Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M,
Suarez C, et al: Papillary thyroid cancer-aggressive variants and
impact on management: A narrative review. Adv Ther. 37:3112–3128.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Feng J, Zhou Q, Yi H, Ma S, Li D, Xu Y,
Wang J and Yin S: A novel lncRNA n384546 promotes thyroid papillary
cancer progression and metastasis by acting as a competing
endogenous RNA of miR-145-5p to regulate AKT3. Cell Death Dis.
10:4332019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yang C and Hardy P: The multifunctional
nature of the MicroRNA/AKT3 regulatory axis in human cancers.
Cells. 12:25942023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Liang H, Cui M, Tu J and Chen X:
Advancements in osteosarcoma management: Integrating immune
microenvironment insights with immunotherapeutic strategies. Front
Cell Dev Biol. 12:13943392024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Cao C and Shu X: Suppression of
circ_0008932 inhibits tumor growth and metastasis in osteosarcoma
by targeting miR-145-5p. Exp Ther Med. 22:11062021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Xie W, Ma F, Dou L, Chang W, Yuan D, Zhang
Z and Zhang Y: Allicin affects immunoreactivity of osteosarcoma
cells through lncRNA CBR3-AS1. Heliyon. 10:e319712024. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
D'Alò F, Bellesi S, Maiolo E, Alma E,
Bellisario F, Malafronte R, Viscovo M, Campana F and Hohaus S:
Novel targets and advanced therapies in diffuse large B cell
lymphomas. Cancers (Basel). 16:22432024. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao Y and Ding X: miR-145-5p exerts
anti-tumor effects in diffuse large B-cell lymphoma by regulating
S1PR1/STAT3/AKT pathway. Leuk Lymphoma. 62:1884–1891. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Guo QQ, Ma SZ, Zhao Y, Beeraka NM, Gu H,
Zheng YF, Zhao RW, Li ST, Nikolenko VN, Bulygin KV, et al:
Association of definitive radiotherapy for esophageal cancer and
the incidence of secondary head and neck cancers: A SEER
population-based study. World J Oncol. 15:598–611. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Niu Y, Zhang J, Tong Y, Li J and Liu B:
miR-145-5p restrained cell growth, invasion, migration and
tumorigenesis via modulating RHBDD1 in colorectal cancer via the
EGFR-associated signaling pathway. Int J Biochem Cell Biol.
117:1056412019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Rajarajan D, Kaur B, Penta D, Natesh J and
Meeran SM: miR-145-5p as a predictive biomarker for breast cancer
stemness by computational clinical investigation. Comput Biol Med.
135:1046012021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
García-García F, Salinas-Vera YM,
García-Vázquez R, Marchat LA, Rodríguez-Cuevas S, López-González
JS, Carlos-Reyes Á, Ramos-Payán R, Aguilar-Medina M,
Pérez-Plasencia C, et al: miR-145-5p is associated with
pathological complete response to neoadjuvant chemotherapy and
impairs cell proliferation by targeting TGFβR2 in breast cancer.
Oncol Rep. 41:3527–3534. 2019.PubMed/NCBI
|
|
89
|
Bagheri M, Khansarinejad B, Mosayebi G,
Moradabadi A and Mondanizadeh M: Diagnostic value of plasma miR-145
and miR-185 as targeting of the APRIL oncogene in the B-cell
chronic lymphocytic leukemia. Asian Pac J Cancer Prev. 22:111–117.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang Y, Ta WW, Sun PF, Meng YF and Zhao
CZ: Diagnostic and prognostic significance of serum miR-145-5p
expression in glioblastoma. Int J Clin Exp Pathol. 12:2536–2543.
2019.PubMed/NCBI
|
|
91
|
Hang W, Feng Y, Sang Z, Yang Y, Zhu Y,
Huang Q and Xi X: Downregulation of miR-145-5p in cancer cells and
their derived exosomes may contribute to the development of ovarian
cancer by targeting CT. Int J Mol Med. 43:256–266. 2019.PubMed/NCBI
|
|
92
|
Aftab M, Poojary SS, Seshan V, Kumar S,
Agarwal P, Tandon S, Zutshi V and Das BC: Urine miRNA signature as
a potential non-invasive diagnostic and prognostic biomarker in
cervical cancer. Sci Rep. 11:103232021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Bahreini F, Saidijam M, Mousivand Z,
Najafi R and Afshar S: Assessment of lncRNA DANCR, miR-145-5p and
NRAS axis as biomarkers for the diagnosis of colorectal cancer. Mol
Biol Rep. 48:3541–3547. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Bahreini F, Saidijam M, Afshar S,
Mousivand Z and Najafi R: The effect of miR-145-5p, DANCR and NRAS
expression levels on the survival rate of colorectal cancer
patients. Asian Pac J Cancer Prev. 22:4043–4049. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wen J, Luo K, Liu H, Liu S, Lin G, Hu Y,
Zhang X, Wang G, Chen Y, Chen Z, et al: MiRNA expression analysis
of pretreatment biopsies predicts the pathological response of
esophageal squamous cell carcinomas to neoadjuvant
chemoradiotherapy. Ann Surg. 263:942–948. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Tuo Z, Liang L and Zhou R: LINC00852 is
associated with poor prognosis in non-small cell lung cancer
patients and its inhibition suppresses cancer cell proliferation
and chemoresistance via the hsa-miR-145-5p/KLF4 axis. J Gene Med.
23:e33842021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Xie L, Cui G and Li T: Long Noncoding RNA
CBR3-AS1 promotes stem-like properties and oxaliplatin resistance
of colorectal cancer by sponging miR-145-5p. J Oncol.
2022:22602112022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhou F, Ding W, Mao Q, Jiang X, Chen J,
Zhao X, Xu W, Huang J, Zhong L and Sun X: The regulation of
hsacirc_004413 promotes proliferation and drug resistance of
gastric cancer cells by acting as a competing endogenous RNA for
miR-145-5p. PeerJ. 10:e126292022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wang W, Ding B, Lou W and Lin S: Promoter
hypomethylation and miR-145-5p downregulation- mediated HDAC11
overexpression promotes sorafenib resistance and metastasis of
hepatocellular carcinoma cells. Front Cell Dev Biol. 8:7242020.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Khalighfard S, Kalhori MR, Amiriani T,
Poorkhani A, Khori V, Esmati E, Lashkari M, Najafi A and Alizadeh
AM: A systematic approach introduced novel targets in rectal cancer
by considering miRNA/mRNA interactions in response to radiotherapy.
Cancer Biomark. 33:97–110. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Tian J, Wang N, Wang C, Wu DP, Wang CH,
Ding XJ and Wang YK: Hsa_circ_0000392 affects the radiation
sensitivity of cervical cancer by targeting the
miR-145-5p/CRKL/MAPK pathway. Zhonghua Zhong Liu Za Zhi.
45:879–891. 2023.(In Chinese). PubMed/NCBI
|
|
102
|
Parayath NN, Gandham SK and Amiji MM:
Tumor-targeted miRNA nanomedicine for overcoming challenges in
immunity and therapeutic resistance. Nanomedicine (Lond).
17:1355–1373. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Luna C, Parker M, Challa P and Gonzalez P:
Long-term decrease of intraocular pressure in rats by viral
delivery of miR-146a. Transl Vis Sci Technol. 10:142021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Sun F, Chen H, Dai X, Hou Y, Li J, Zhang
Y, Huang L, Guo B and Yang D: Liposome-lentivirus for miRNA therapy
with molecular mechanism study. J Nanobiotechnology. 22:3292024.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Xu J, Liu W, Fan F, Zhang B, Sun C and Hu
Y: Advances in nano-immunotherapy for hematological malignancies.
Exp Hematol Oncol. 13:572024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fan B, Yang X, Li X, Lv S, Zhang H, Sun J,
Li L, Wang L, Qu B, Peng X and Zhang R:
Photoacoustic-imaging-guided therapy of functionalized melanin
nanoparticles: Combination of photothermal ablation and gene
therapy against laryngeal squamous cell carcinoma. Nanoscale.
11:6285–6296. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Dai J, Cheng Y, Wu J, Wang Q, Wang W, Yang
J, Zhao Z, Lou X, Xia F, Wang S and Tang BZ: Modular peptide probe
for Pre/Intra/Postoperative therapeutic to reduce recurrence in
ovarian cancer. ACS Nano. 14:14698–14714. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wang X, Li F, Zhang J, Guo L, Shang M, Sun
X, Xiao S, Shi D, Meng D, Zhao Y, et al: A combination of
PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted
microbubble destruction for tumor immunotherapy. J Control Release.
367:45–60. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ren L, Wang L, Yi X, Tan Y, Yi L, He J and
Li D: Ultrasound microbubble-stimulated miR-145-5p inhibits
malignant behaviors of breast cancer cells by targeting ACTG1.
Ultrasound Q. 40:136–143. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Jiang T, Qiao Y, Ruan W, Zhang D, Yang Q,
Wang G, Chen Q, Zhu F, Yin J, Zou Y, et al: Cation-Free siRNA
micelles as effective drug delivery platform and potent RNAi
nanomedicines for glioblastoma therapy. Adv Mater. 33:e21047792021.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Howe SJ, Mansour MR, Schwarzwaelder K,
Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K,
Chatters SJ, de Ridder D, et al: Insertional mutagenesis combined
with acquired somatic mutations causes leukemogenesis following
gene therapy of SCID-X1 patients. J Clin Invest. 118:3143–3150.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Jusoh AR, Mohan SV, Ping TL, Din TADAAB,
Haron J, Romli RC, Jaafar H, Nafi SN, Salwani TI and Yahya MM:
Plasma circulating mirnas profiling for identification of potential
breast cancer early detection biomarkers. Asian Pac J Cancer Prev.
22:1375–1381. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
García-Magallanes N, Beltran-Ontiveros SA,
Leal-León EA, Luque-Ortega F, Romero-Quintana JG, Osuna-Ramirez I,
Barbosa-Jasso M and Arámbula-Meraz E: Underexpression of
circulating miR-145-5p and miR-133a-3p are associated with breast
cancer and immunohistochemical markers. J Cancer Res Ther.
16:1223–1228. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim
DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective
release of microRNA species from normal and malignant mammary
epithelial cells. PLoS One. 5:e135152010. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Hernandez BJ, Strain M, Suarez MF, Stamer
WD, Ashley-Koch A, Liu Y, Klingeborn M and Rickman CB: Small
extracellular vesicle-associated MiRNAs in polarized retinal
pigmented epithelium. Invest Ophthalmol Vis Sci. 65:572024.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Guo Y, Han Y, Zhang J, Zhou Y, Wei M and
Yu L: Identification and experimental validation of prognostic
miRNA signature and ferroptosis-related key genes in cervical
squamous cell carcinoma. Cancer Med. 13:e704152024. View Article : Google Scholar : PubMed/NCBI
|
